Revolution Medicines, Inc.
RVMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,336,846 | $3,245,138 | $1,920,524 | $1,832,529 |
| - Cash | $543,064 | $696,148 | $161,412 | $108,497 |
| + Debt | $135,843 | $87,944 | $64,205 | $66,633 |
| Enterprise Value | $6,929,625 | $2,636,934 | $1,823,317 | $1,790,665 |
| Revenue | $0 | $11,580 | $35,380 | $29,390 |
| % Growth | -100% | -67.3% | 20.4% | – |
| Gross Profit | -$592,225 | -$399,664 | -$217,693 | -$157,558 |
| % Margin | – | -3,451.3% | -615.3% | -536.1% |
| EBITDA | -$589,022 | -$456,675 | -$248,623 | -$179,747 |
| % Margin | – | -3,943.7% | -702.7% | -611.6% |
| Net Income | -$600,093 | -$436,367 | -$248,705 | -$187,091 |
| % Margin | – | -3,768.3% | -703% | -636.6% |
| EPS Diluted | -3.58 | -3.86 | -3.08 | -2.47 |
| % Growth | 7.3% | -25.3% | -24.7% | – |
| Operating Cash Flow | -$557,436 | -$350,572 | -$224,401 | -$147,180 |
| Capital Expenditures | -$10,308 | -$7,729 | -$10,816 | -$6,528 |
| Free Cash Flow | -$567,744 | -$358,301 | -$235,217 | -$153,708 |